glp-1 colorectal cancer risk study november 2025 Could medications help slow progression?⁣ ⁣ A new Cleveland Clinic found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to GLP-1 drugs and colorectal cancer

Our Elite Longevity & Performance Stack combines NAD with Tesamorelin/Ipamorelin in a single, physicianguided protocol designed to support cellular energy, body composition , sleep, and longterm vitality so you can keep showing up at a high level in work, training, and life

A significant dose-dependent relationship between mercury exposure from dental amalgams and kidney integrity biomarkers: a further assessment of the Casa Pia childrens dental amalgam trial

Recently, glucagon-like peptide 1 (GLP-1) agonists have garnered interest for IIH management due to their weight reduction and potential CSF production-decreasing effects

17 The formation of peroxynitrite occurs when superoxide radicals interact with nitric oxide, resulting in nitrotyrosine adducts within mitochondria

GLP-1 medications independently reduce hepatic fat and improve insulin sensitivity, so isolating lipotropic benefit requires careful interpretation